ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: TH-PO523

Membranoproliferative Glomerulonephritis (MPGN) in the Setting of Unicentric Castleman Disease

Session Information

Category: Glomerular Diseases

  • 1303 Glomerular Diseases: Clinical‚ Outcomes‚ and Trials

Authors

  • Rizvi, Ali Waris, Allegheny Health Network, Pittsburgh, Pennsylvania, United States
  • Kobrin, Dale Matthew, Allegheny Health Network, Pittsburgh, Pennsylvania, United States
  • Gupta, Naman, Allegheny Health Network, Pittsburgh, Pennsylvania, United States
  • Turk, Michael, Allegheny Health Network, Pittsburgh, Pennsylvania, United States
  • Muaddi, Luba, Allegheny Health Network, Pittsburgh, Pennsylvania, United States
  • Arora, Swati, Allegheny Health Network, Pittsburgh, Pennsylvania, United States
Introduction

Castleman’s disease (CD) is a rare lymphoproliferative disorder with histopathological abnormalities - divided primarily into unicentric and multicentric disease. Thought to be an inflammatory process, renal involvement has been described extensively in the setting of multicentric disease, especially associated with HHV-8. However, similar reports in unicentric disease are rather limited.

Case Description

A 33 year old female with asthma developed hematuria and proteinuria in the setting of chronic right flank pain and intermittent night sweats for about 2 years. With a stable creatinine (Cr) level of 0.7 mg/dL, blood work was negative for C3, C4, cryoglobulins, and hepatitis panels. UA showed no hematuria, but did reveal 0.6 - 1.0 g of proteinuria. Imaging revealed 2 mesenteric soft tissue nodules, largest measuring 2.4 cm. A renal biopsy was significant for immune complex MPGN with kappa and c3. PET-CT at 1 year revealed hypermetabolic mesenteric nodules suspicious for malignancy. Nodular biopsy showed atypical B-lymphoid infiltrate initially concerning for marginal cell lymphoma. Referral to Mayo Clinic was confirmatory for hyaline vascular unicentric Castleman’s disease. HHV8, PCR for B-cell receptor gene rearrangement and FISH for t(11;18) were negative. Referral made to Rheumatology for MPGN and moderate concern for systemic lupus erythematosus (SLE) with ANA 1:160 and BC4d, however no systemic symptoms of SLE. Follow-up imaging showed a decrease in lymphadenopathy from 2.3 to 1.6 cm, with plan for conservative management. Patient's proteinuria persisted at 821.5 mg with plan for ACE inhibitor but avoided in the setting of the patient's third pregnancy.

Discussion

Renal involvement is typical in multicentric CD so, we present a unique case of unicentric CD associated with MPGN. Persistent proteinuria and MPGN with ANA 1:160 and BC4d placed lupus nephritis versus Castleman’s induced nephropathy on the differential. However, lack of SLE symptoms, normal complement and double stranded DNA indicated a unique disease presentation of Castleman’s with proteinuria.